Market Overview:
The global cell therapy bioprocessing market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for regenerative therapies, rising prevalence of chronic diseases, and technological advancements in cell-based therapies. Based on type, the global cell therapy bioprocessing market is segmented into immune cells, human embryonic stem cells (hESCs), pluripotent stem cells (PSCs), and hematopoetic stem cells (HSCs). Of these, hESCs are expected to witness the highest growth during the forecast period owing to their ability to differentiate into any type of tissue or organ. By application, the market is segmented into cardiovascular disease (CVD), oncology, wound healing, orthopedic applications,, and others. CVD is expected to account for the largest share of this market in 2018 owingto its high prevalence worldwide.
Product Definition:
Cell therapy bioprocessing is a process that uses cells to treat or prevent disease. The cells are usually taken from the patient's own body, but they can also come from a donor. Cell therapy bioprocessing is important because it can help improve the quality of life for patients with diseases such as cancer, heart disease, and diabetes.
Immune Cell:
Immune cells are the body's immune system, they are responsible for protecting the host from foreign bodies such as bacteria and viruses. There are many types of immune cells including T-cell, B-cell, natural killer cell and macrophage. These play a major role in adaptive immunity (e.g., antibody production) and protective immunity (e.g., cell-mediated & humoral immunities).
Human Embryonic Stem Cells:
Human embryonic stem cells (hESC) are the inner cell mass of blastocyst stage embryos. They possess the ability to become all the tissues and organs of the human body. hESCs have been widely used for research purposes owing to their pluripotent nature, which enables them to develop into any type of tissue or organ in vivo.
Application Insights:
The others segment held the largest share of revenue in 2017. This includes neurological disease, diabetes, ophthalmic diseases and skin disorders. The rising prevalence of chronic conditions is anticipated to boost the demand for cell therapies in various applications over the forecast period.
Oncology accounted for a significant share in terms of revenue as well as application type and is expected to maintain its dominance throughout the forecast period owing to increasing cancer cases globally. According to WHO, an estimated 9 million people died due to cancer worldwide in 2016; however, this number could be reduced by about 80% if diagnosed early with effective treatment options such as cell therapy available today.
Regional Analysis:
North America dominated the global cell therapy bioprocessing market in 2017. The presence of a large number of biopharmaceutical manufacturers and well-established healthcare infrastructure are some factors that can be attributed to this dominance. In addition, increasing investments by major players for the development of advanced technologies is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income, improving healthcare facilities and an increase in investment by various public & private entities for developing new therapies using cell therapy products. Moreover, growing awareness regarding stem cell research and increased focus on clinical trials conducted using cells derived from human embryonic stem cells contributed significantly towards regional growth in 2017.
Growth Factors:
- Increasing demand for cell therapies for various diseases
- Growing number of cell therapy clinical trials
- Rising public and private investment in cell therapy research and development
- Technological advancements in cell therapy bioprocessing
- Growing number of partnerships and collaborations between pharmaceutical companies, biotech firms, and academic institutions
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Therapy Bioprocessing Market Research Report
By Type
Immune Cell, Human Embryonic Stem Cells, Pluripotent Stem Cells Stem Cell, Hematopoetic Stem Cells
By Application
Cardiovascular Disease (CVD), Oncology, Wound Healing, Orthopedic, Others
By Companies
Fresenius Medical Care, Omnica Corporation, Medtronic, Baxter International, B. Braun, Nikkiso, Asahi Kasei Medical, Infomed, Bellco
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Cell Therapy Bioprocessing Market Report Segments:
The global Cell Therapy Bioprocessing market is segmented on the basis of:
Types
Immune Cell, Human Embryonic Stem Cells, Pluripotent Stem Cells Stem Cell, Hematopoetic Stem Cells
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular Disease (CVD), Oncology, Wound Healing, Orthopedic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius Medical Care
- Omnica Corporation
- Medtronic
- Baxter International
- B. Braun
- Nikkiso
- Asahi Kasei Medical
- Infomed
- Bellco
Highlights of The Cell Therapy Bioprocessing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immune Cell
- Human Embryonic Stem Cells
- Pluripotent Stem Cells Stem Cell
- Hematopoetic Stem Cells
- By Application:
- Cardiovascular Disease (CVD)
- Oncology
- Wound Healing
- Orthopedic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Therapy Bioprocessing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell therapy bioprocessing is a process that uses cells to treat diseases. The cells are taken from a person or animal and put into a machine that helps them grow and divide. This process is then used to treat the person or animal who has the disease.
Some of the major companies in the cell therapy bioprocessing market are Fresenius Medical Care, Omnica Corporation, Medtronic, Baxter International, B. Braun, Nikkiso, Asahi Kasei Medical, Infomed, Bellco.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Therapy Bioprocessing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell Therapy Bioprocessing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell Therapy Bioprocessing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell Therapy Bioprocessing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell Therapy Bioprocessing Market Size & Forecast, 2018-2028
4.5.1 Cell Therapy Bioprocessing Market Size and Y-o-Y Growth
4.5.2 Cell Therapy Bioprocessing Market Absolute $ Opportunity
Chapter 5 Global Cell Therapy Bioprocessing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cell Therapy Bioprocessing Market Size Forecast by Type
5.2.1 Immune Cell
5.2.2 Human Embryonic Stem Cells
5.2.3 Pluripotent Stem Cells Stem Cell
5.2.4 Hematopoetic Stem Cells
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cell Therapy Bioprocessing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cell Therapy Bioprocessing Market Size Forecast by Applications
6.2.1 Cardiovascular Disease (CVD)
6.2.2 Oncology
6.2.3 Wound Healing
6.2.4 Orthopedic
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Therapy Bioprocessing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Therapy Bioprocessing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cell Therapy Bioprocessing Analysis and Forecast
9.1 Introduction
9.2 North America Cell Therapy Bioprocessing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cell Therapy Bioprocessing Market Size Forecast by Type
9.6.1 Immune Cell
9.6.2 Human Embryonic Stem Cells
9.6.3 Pluripotent Stem Cells Stem Cell
9.6.4 Hematopoetic Stem Cells
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cell Therapy Bioprocessing Market Size Forecast by Applications
9.10.1 Cardiovascular Disease (CVD)
9.10.2 Oncology
9.10.3 Wound Healing
9.10.4 Orthopedic
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cell Therapy Bioprocessing Analysis and Forecast
10.1 Introduction
10.2 Europe Cell Therapy Bioprocessing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cell Therapy Bioprocessing Market Size Forecast by Type
10.6.1 Immune Cell
10.6.2 Human Embryonic Stem Cells
10.6.3 Pluripotent Stem Cells Stem Cell
10.6.4 Hematopoetic Stem Cells
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cell Therapy Bioprocessing Market Size Forecast by Applications
10.10.1 Cardiovascular Disease (CVD)
10.10.2 Oncology
10.10.3 Wound Healing
10.10.4 Orthopedic
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cell Therapy Bioprocessing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cell Therapy Bioprocessing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cell Therapy Bioprocessing Market Size Forecast by Type
11.6.1 Immune Cell
11.6.2 Human Embryonic Stem Cells
11.6.3 Pluripotent Stem Cells Stem Cell
11.6.4 Hematopoetic Stem Cells
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cell Therapy Bioprocessing Market Size Forecast by Applications
11.10.1 Cardiovascular Disease (CVD)
11.10.2 Oncology
11.10.3 Wound Healing
11.10.4 Orthopedic
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cell Therapy Bioprocessing Analysis and Forecast
12.1 Introduction
12.2 Latin America Cell Therapy Bioprocessing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cell Therapy Bioprocessing Market Size Forecast by Type
12.6.1 Immune Cell
12.6.2 Human Embryonic Stem Cells
12.6.3 Pluripotent Stem Cells Stem Cell
12.6.4 Hematopoetic Stem Cells
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cell Therapy Bioprocessing Market Size Forecast by Applications
12.10.1 Cardiovascular Disease (CVD)
12.10.2 Oncology
12.10.3 Wound Healing
12.10.4 Orthopedic
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cell Therapy Bioprocessing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cell Therapy Bioprocessing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cell Therapy Bioprocessing Market Size Forecast by Type
13.6.1 Immune Cell
13.6.2 Human Embryonic Stem Cells
13.6.3 Pluripotent Stem Cells Stem Cell
13.6.4 Hematopoetic Stem Cells
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cell Therapy Bioprocessing Market Size Forecast by Applications
13.10.1 Cardiovascular Disease (CVD)
13.10.2 Oncology
13.10.3 Wound Healing
13.10.4 Orthopedic
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Therapy Bioprocessing Market: Competitive Dashboard
14.2 Global Cell Therapy Bioprocessing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fresenius Medical Care
14.3.2 Omnica Corporation
14.3.3 Medtronic
14.3.4 Baxter International
14.3.5 B. Braun
14.3.6 Nikkiso
14.3.7 Asahi Kasei Medical
14.3.8 Infomed
14.3.9 Bellco
